PDF
DataM
Asia Pacific Diagnostic Imaging Market Report
SKU: MI7618

Asia Pacific Diagnostic Imaging Market Size, Share, Growth, Forecast and outlook (2024-2031)

Last Updated: || Author: Rohan Sawant || Reviewed: Akshay Reddy

Market Size & Forecast
Competitive Analysis
Partner Identification
Unmet Needs
Regulatory Compliance
Opportunity Analysis

Stop Guessing and Start Converting. 81% of our Clients purchase reports tailored to their exact business goals.

Report Summary
Table of Contents
List of Tables & Figures

Asia Pacific Diagnostic Imaging Market is segmented By Type (X-Ray, MRI, Nuclear Medicine, SPECT Imaging, Ultrasound, Tomography, Tactile Imaging, Functional Infrared Spectroscopy) By Application (Orthopedic, Neurology, Oncology, Cardiology, Others) By End User (Hospitals, Diagnostics, Imaging Centers, Others) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

 

Report Overview

Asia Pacific Diagnostic Imaging Market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031. 

Diagnostic imaging is a medical specialty wherein clinicians rebuild images of different body parts for diagnostic and therapeutic reasons. Clinicians may use non-invasive diagnostic imaging technologies to identify injuries and illnesses without becoming intrusive. 

The rising prevalence of chronic diseases, such as cardiovascular and neurologic issues, along with the restructuring of healthcare systems, has resulted in a greater focus on early detection.

 

Asia Pacific Diagnostic Imaging Market Summary

Metrics

Details

CAGR

YY%

Market Size Available for Years

2022-2031

Estimation Forecast Period

2024-2031

Revenue Units

Value (US$ Mn) 

Segments Covered

Type, Application, End User

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.


For more details on this report – Request for Sample

 

Asia Pacific Diagnostic Imaging Market Dynamics

Increasing technological advancements 

Technological breakthroughs in diagnostic imaging models, as well as increasing investment, financing, and subsidies from public and commercial organizations, produced a need for diagnostic imaging methods in this area are the driving factors of the market growth. 

For instance, in May 2022, Chinese researchers successfully developed a superconducting magnet for the world-leading magnetic resonance imaging (MRI) system, making China the first Asian country to possess the technology.

Additionally, in February 2024, Butterfly Network unveiled the iQ3TM handheld ultrasound that has a combination of enhanced image processing, artificial intelligence (AI) tools and improved 3D imaging, 

High cost of the equipment  

The cost of buying and maintaining diagnostic imaging equipment, such as MRI machines, CT scanners, and PET scanners, is very high. For smaller healthcare facilities, this presents a major obstacle, and it may also restrict access to this technology in underdeveloped nations.

Asia Pacific Diagnostic Imaging Market Segment Analysis

The Asia Pacific diagnostic imaging market is segmented based on type, application, and end user.

MRI segment is expected to dominate the market growth

MRI diagnostic imaging is anticipated to hold a major position in the market share. This is expected due to the increasing number of products of MRI systems for diagnosis. 

For example, Canon Medical unveiled the Vantage Fortain MRI System at ECR 2022 in July 2022. Concurrently aiding in reducing MRI imaging time are innovative workflow solutions, image enhancements, and high-rate scan technology incorporated into this system.

Additionally, in August 2023, Voxelgrids, an India-based company launched an advanced and affordable MRI scanner with the potential to revolutionize healthcare accessibility not only in India but also worldwide. Thus, the above factors are expected to hold the segment in the dominant position during the forecast period.

COVID-19 Impact Analysis

COVID-19 has affected the market growth negatively. Delays or avoidance of elective procedures and normal checks were caused by lockdowns and social distancing measures. Consequently, there was a notable decrease in the number of elective MRIs that use diagnostic imaging modalities, such as mammograms and colonoscopies. Delays and cancellations of non-emergency diagnostic imaging operations resulted from hospitals prioritizing the treatment of COVID-19 patients with limited resources. 

Asia Pacific Diagnostic Imaging Market Key Players

The major players in the market include GE HealthCare, Siemens Healthcare Private Limited, Toshiba Medical Systems Corporation, CANON MEDICAL SYSTEMS CORPORATION, FUJIFILM Corporation, Shimadzu Corporation, Elekta AB, Esaote SPA, Mindray Medical International Limited, Narang Medical among others.

Why Purchase the Report?

  • To visualize the Asia Pacific diagnostic imaging market segmentation based on type, application, and end user as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development. 
  • Excel data sheet with numerous data points of diagnostic imaging market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The Asia Pacific diagnostic imaging market report would provide approximately 53 tables, 47 figures and 176 pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
FAQ’s

  • GE HealthCare, Siemens Healthcare Private Limited, Toshiba Medical Systems Corporation, CANON MEDICAL SYSTEMS CORPORATION, FUJIFILM Corporation, Shimadzu Corporation, Elekta AB, Esaote SPA, Mindray Medical International Limited and Narang Medical.

  • Asia Pacific Diagnostic Imaging Market is estimated to grow at a high CAGR during the forecast period 2024-2031
PDF
DataM
Asia Pacific Diagnostic Imaging Market Report
SKU: MI7618

Data-Backed Decisions Start Here

Explore how our research empowers industry leaders to cut through uncertainty. Get a free sample of this report or tailor it precisely to your business needs.

ISO 27001 Certified
ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
Related Reports